A Spinach Ingredient for Appetite Suppression
Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Thylakoids are membrane-bound compartments found inside the chloroplasts of plant cells. According to Green Leaf, in vitro and in vivo studies indicate that these substances can prevent fat and carbohydrate assimilation and promote appetite reduction for at least six hours.
While the company is planning long-term studies for 2011 and 2012 and preparing for US and EU regulatory processes, Green Leaf says that it will have a market-ready product by 2012. The company continues to explore its ingredient for use in dietary supplements, functional foods, and beverages.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
